Specific transduction of HIV-1 envelope expressing cells by retroviral vectors pseudotyped with hybrid CD4/CXCR4 receptors

Journal of Virological Methods

Volumn 104, Issue 1, 2002, Pages 83-92

  Bittner, Alexandra ^a   Mitnacht Kraus, Rita ^a,b   Schnierle, Barbara S ^a  

^a Institute for Biomedical Research   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

CD4; CXCR4; Envelope; Retroviral vectors

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ENVELOPE PROTEIN; RETROVIRUS VECTOR; VIRUS VECTOR;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYBRID GENE; LENTIVIRINAE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TARGET CELL; VIRUS ENVELOPE; VIRUS EXPRESSION;

ANTIGENS, CD4; CELL LINE, TRANSFORMED; FUSION PROTEINS, GAG-POL; GENE PRODUCTS, REV; GENETIC VECTORS; HIV-1; HUMANS; LENTIVIRUS; LEUKEMIA VIRUS, MURINE; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE; MURINE LEUKEMIA VIRUS;

EID: 0036090949     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(02)00043-5     Document Type: Article

References (25)

1. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities
2. Approaches to gene therapy for human immunodeficiency virus infection
3. How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity
4. A third-generation lentivirus vector with a conditional packaging system
5. Targeting of HIV-and SIV-infected cells by CD4-chemokine receptor pseudotypes
6. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: Rapid internalization and recycling upon activation
7. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering
8. Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of additional cellular interaction partner
9. Incorporation of wild-type and C-terminally truncated human epidermal growth factor receptor into human immunodeficiency virus-like particles: Insight into the processes governing glycoprotein incorporation into retroviral particles
10. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles
11. + lymphoid cells
12. CD4-chemokine receptor hybrids in human immunodeficiency virus type 1 infection
13. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins
14. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
15. + cells
16. A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells
17. Production of high-titer helper-free retroviruses by transient transfection
18. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection
19. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells
20. Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping
21. A transient three-plasmid expression system for the production of high titer retroviral vectors
22. Membrane fusion between retroviral particles: Host-range extension and vaccine prospects
23. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein
24. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes